Publications
CMS subtypes correlate with complete response in trial of neoadjuvant Galunisertib plus chemoradiation in rectal cancer
Journal article
Rajamanickam V. et al, (2026), Translational Oncology, 66, 102690 - 102690
ESR1 Mutation in Endocrine Treatment-Naïve Endometrial Cancer: Prevalence, Characteristics, and Prognostic Implications, Results from the UTOLA Phase II GINECO Trial
Journal article
Blanc-Durand F. et al, (2026), Clinical Cancer Research, 32, 963 - 969
News
Dr Alexander Mentzer Named NIHR Oxford Senior Research Fellow
22 January 2026
Biomedical Research Career Week 13-17th July 2026
24 November 2025
Oxford University to accelerate T1D research and care with £10m gift
30 September 2025
Seminars
-
Tuesday, 17 March 2026, 9.30am to 10.30am
-
Wednesday, 18 March 2026, 12.30pm to 1.30pm
-
Thursday, 19 March 2026, 12pm to 1pm
